Literature DB >> 18627011

Development of novel perfusion chamber to retain nonadherent cells and its use for comparison of human "mobilized" peripheral blood mononuclear cell cultures with and without irradiated bone marrow stroma.

C E Sandstrom1, J G Bender, W M Miller, E T Papoutsakis.   

Abstract

Perfusion and static cultures of peripheral blood (PB) mononuclear cells (MNCs), obtained from patients following stem cell mobilization, were supplemented with interleukin-3 (IL-3), IL-6, granulocyte colony-stimulating factor (G-CSF), and stem cell factor (SCF) and compared with and without a preformed irradiated allogeneic bone marrow stromal layer. Perfusion cultures without a stromal layer effectively retained nonadherent cells through the use of a novel "grooved" perfusion chamber, which was designed with minimal mass transfer barriers in order to achieve a well-defined culture environment. The grooved chamber allowed easy and efficient culture inoculation and cell recovery. Average maximum expansion of CFU-GM (colony-forming unit granulocyte-macrophage) cells was observed on day 10 for all cultures. Perfusion cultures had a maximum CFU-GM expansion of 17- and 19-fold with and without a stromal layer, respectively. In contrast, static cultures had a maximum CFU-GM expansion of 18- and 13-fold with and without a stromal layer, respectively. Average long-term-culture initiating cell (LTC-IC) numbers on day 15 were 34% and 64% of input in stroma-containing and stroma-free perfusion cultures and 12% and 11% of input in stroma-containing and stroma-free static cultures, respectively. Thus, perfusion enhanced CFU-GM expansion and LTC-IC maintenance more for the stroma-free cultures than for stroma-containing cultures. This was surprising because analysis of medium supernatants indicated that the stroma-containing cultures were metabolically more active than the stroma-free cultures. In view of their equivalent, if not superior, performance compared to stroma-containing cultures, stroma-free perfusion cultures may offer significant advantages for potential clinical applications.

Entities:  

Year:  1996        PMID: 18627011     DOI: 10.1002/(SICI)1097-0290(19960605)50:5<493::AID-BIT3>3.0.CO;2-A

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

Review 1.  Scalable stirred-suspension bioreactor culture of human pluripotent stem cells.

Authors:  Daniel E Kehoe; Donghui Jing; Lye T Lock; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

2.  Transport and shear in a microfluidic membrane bilayer device for cell culture.

Authors:  Niraj K Inamdar; Linda G Griffith; Jeffrey T Borenstein
Journal:  Biomicrofluidics       Date:  2011-06-29       Impact factor: 2.800

3.  Microfabricated electrospun collagen membranes for 3-D cancer models and drug screening applications.

Authors:  Olga Hartman; Chu Zhang; Elizabeth L Adams; Mary C Farach-Carson; Nicholas J Petrelli; Bruce D Chase; John F Rabolt
Journal:  Biomacromolecules       Date:  2009-08-10       Impact factor: 6.988

4.  Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions.

Authors:  A De León; H Mayani; O T Ramírez
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

5.  Predictions for optimal mitigation of paracrine inhibitory signalling in haemopoietic stem cell cultures.

Authors:  Joseph D Berry; Pankaj Godara; Petar Liovic; David N Haylock
Journal:  Stem Cell Res Ther       Date:  2015-04-16       Impact factor: 6.832

6.  3D models of the hematopoietic stem cell niche under steady-state and active conditions.

Authors:  Lisa Rödling; Ivo Schwedhelm; Saskia Kraus; Karen Bieback; Jan Hansmann; Cornelia Lee-Thedieck
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.